Earl Martin Douglas - 03 Feb 2025 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: SVP, General Counsel
Signature: /s/Earl Douglas
Issuer symbol: ALLO
Transactions as of: 03 Feb 2025
Net transactions value: -$10,951
Form type: 4
Filing time: 05 Feb 2025, 16:16:37 UTC
Previous filing: 28 Jan 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Sale	$10,951	-6,404	-1.1%	$1.71	587,848	03 Feb 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Content

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.